
|Articles|November 6, 2007
Eden Biodesign Appoints Roger Lias as President of US Division
Author(s)BioPharm International Editors
Eden Biodesign Ltd., (Liverpool, UK) has appointed Roger Lias, PhD, president of Eden Biodesign, US. Lias has extensive experience in the biotechnology industry with a specific emphasis on biomanufacturing services.
Advertisement
Eden Biodesign Ltd., (Liverpool, UK) has appointed Roger Lias, PhD, president of Eden Biodesign, US. Lias has extensive experience in the biotechnology industry with a specific emphasis on biomanufacturing services. Lias joins Eden Biodesign from Cytovance Biologics, where he was vice president of sales and business development since 2004.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
2
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
3
Accelerate Your Biologic with HEK Cell Lines
4




